$4.56
Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
Bausch Health Poised to Report Q2 Consolidated Revenue of $2.73 Billion, RBC Capital Markets Says
Bausch Health’s (BHC) Canadian Subsidiary Lists PrOKEDI Dosages in RAMQ Formulary
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026
Overview
52-week range
$4.61
$8.69
0% of range
Avg surprise (last 2)
-18.1%
Avg reaction (last 1)
-3.8%
0% positive
Latest IV / EM
70%
EM ±8.8% · $5 · Jul 31
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $-3.82 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.48 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $0.90 | $0.97 | -7.2% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $0.59 | $0.83 | -28.9% | — | -3.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.23 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.03 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.17 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.03 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.07 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Jul 29, 2026 | Jun/2026 | AMC | $0.96 | $0.90 | +6.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-950M | — | $619M | $444M | $276M | — | $318M | $389M |
| Net income | $-1.42B | — | $179M | $148M | $-58M | — | $-85M | $10M |
| EPS (diluted) | $-3.82 | — | $0.48 | $0.40 | $-0.16 | — | $-0.23 | $0.03 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.30B | $1.31B | $1.31B | $1.73B | $1.13B | $1.18B | $719M | $595M |
| Inventory | $1.60B | $1.63B | $1.60B | $1.66B | $1.61B | $1.59B | $1.66B | $1.61B |
| Total current assets | $5.98B | $6.16B | $6.25B | $6.51B | $5.73B | $5.77B | $5.35B | $5.21B |
| Total assets | $24.50B | $26.37B | $26.82B | $27.27B | $26.42B | $26.52B | $26.54B | $26.50B |
| Long-term debt | $19.88B | $20.59B | $20.46B | $20.86B | $21.23B | $18.94B | $21.05B | $21.21B |
| Total liabilities | $25.58B | $25.99B | $26.47B | $27.12B | $26.66B | $26.84B | $26.78B | $26.72B |
| Total equity | $-2.06B | $-554M | $-565M | $-764M | $-1.18B | $-1.28B | $-1.17B | $-1.18B |